Global RNA Therapeutics Supply, Demand and Key Producers, 2023-2029

Global RNA Therapeutics Supply, Demand and Key Producers, 2023-2029

The global RNA Therapeutics market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

RNA therapeutics, also known as RNA-based therapeutics or RNA medicines, refer to a class of medical treatments that utilize RNA molecules to intervene in gene expression and regulation within cells. RNA (ribonucleic acid) is a vital molecule in cells responsible for various biological processes, including protein synthesis and gene regulation.

This report studies the global RNA Therapeutics demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for RNA Therapeutics, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of RNA Therapeutics that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global RNA Therapeutics total market, 2018-2029, (USD Million)

Global RNA Therapeutics total market by region & country, CAGR, 2018-2029, (USD Million)

U.S. VS China: RNA Therapeutics total market, key domestic companies and share, (USD Million)

Global RNA Therapeutics revenue by player and market share 2018-2023, (USD Million)

Global RNA Therapeutics total market by Type, CAGR, 2018-2029, (USD Million)

Global RNA Therapeutics total market by Application, CAGR, 2018-2029, (USD Million).

This reports profiles major players in the global RNA Therapeutics market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Moderna, Alnylam Pharmaceuticals, Novartis, Ionis Pharmaceuticals, Sarepta Therapeutics, Sanofi, Pfizer, Arrowhead Pharmaceuticals and BioNTech, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World RNA Therapeutics market.

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global RNA Therapeutics Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global RNA Therapeutics Market, Segmentation by Type
mRNA
RNA Interference (RNAi)
Antisense Oligonucleotide (ASO)
Other

Global RNA Therapeutics Market, Segmentation by Application
Hospitals
Research Institutions

Companies Profiled:
Moderna
Alnylam Pharmaceuticals
Novartis
Ionis Pharmaceuticals
Sarepta Therapeutics
Sanofi
Pfizer
Arrowhead Pharmaceuticals
BioNTech
Orna Therapeutics
CRISPR Therapeutics
Silence Therapeutics
Astellas Pharma Inc.
CureVac
Sirnaomics
Arcturus Therapeutics
Arbutus Biopharma

Key Questions Answered

1. How big is the global RNA Therapeutics market?

2. What is the demand of the global RNA Therapeutics market?

3. What is the year over year growth of the global RNA Therapeutics market?

4. What is the total value of the global RNA Therapeutics market?

5. Who are the major players in the global RNA Therapeutics market?